The NAFLD group had higher BMI, SBP, DBP, ALT, TP, ALB, SCR, TGs, FBG, LDL-C, and HbA1c and lower HDL-C. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.